Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging
Abroad (travel likely)RecruitingPHASE4
Conditions
Focal Liver Lesions
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Munich University Hospital, München, Germany
Papa Giovanni XXIII Hospital, Bergamo, Italy
Giannina Gaslini Institute, Genoa, Italy
University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
King's College Hospital NHS Foundation Trust, London, United Kingdom
Imperial College Healthcare NHS Trust, London, United Kingdom
Study leads
David Thompson
Study Director
GE Healthcare